Brief: Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice
17/06/2022 21:32
Tiziana Life Sciences Ltd TLSA.O :
* TIZIANA LIFE SCIENCES LTD. RECEIVES NASDAQ DEFICIENCY
NOTICE
Source text for Eikon: ID:nGNX4yWsBk
Further company coverage: TLSA.O
Recent news on Tiziana Life Sciences
See all newsTiziana's experimental MS treatment meets main goals in mid-stage study
Brief: Tiziana Life Sciences - Submits Request To FDA For Orphan Drug Designation For Intranasal Foralumab For Msa
Brief: Tiziana Announces Last Patient Completes Last Visit In Phase 2A Inform-MS Trial Of Intranasal Foralumab
Brief: Tiziana Announces Last Patient Successfully Dosed In Its Phase 2 Inform-MS Trial
Brief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis